Clinical Trials Browser

Phase 1 × Interventional × Oncogenic osteomalacia × Clear all

NCT04689893 2021-01-05

Application of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in the Diagnosis and Evaluation of TIO

Phase 1 Unknown

Oncogenic osteomalacia

NCT01748812 2018-07-05

Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)

Phase 1 Terminated

Oncogenic osteomalacia, Osteomalacia, Rickets, Hypophosphatemic